Staged Percutaneous Treatment of Severe Carcinoid Heart Disease by Transfemoral Pulmonary Valve Replacement and Novel Vena Cava Valve Implantation Abstract #1138

Introduction: Carcinoid heart disease with severe valve destruction represents the major cause of high morbidity and mortality in patients with carcinoid syndrome.
Aim(s): In this case report, we present a patient suffering advanced carcinoid heart disease at whom a two-stage minimally invasive percutaneous approach for management of severe pulmonary and tricuspid valve regurgitation was applied for the first time.
Materials and methods: A patient with an ileal neuroendocrine tumour (G2, Ki67: 5%) presented with right heart failure (NYHA IV). Echocardiography disclosed advanced carcinoid heart disease affecting both the pulmonary and the tricuspid valves. A balloon-expandable 29-mm Edwards SAPIEN XT was successfully implanted percutaneously into the pulmonary valve. Since no catheter-based techniques were available for the replacement of the native tricuspid valve, we designed a novel approach to reduce the abdominal congestion: for the first time we implanted an Edwards SAPIEN 26-mm valve into the ICV between the right atrium and the ostium of the hepatic veins, which completely prevented regurgitation into the VCI and abdominal veins.
Conference: 12th Annual ENETS Conference 2015 (2015)
Category: Clinical cases/reports
Presenting Author: Dr René Pschowski

To read results and conclusion, please login ...

Further abstracts you may be interested in

No result